Consulting for COVID-19 drug development

biostats 300x225

Service description

  • The support of R&D projects by experts and specialized firms can be essential in the development of a drug. This enables informed choices to be made more quickly, which is necessary for emergency situations such as those generated by the COVID-19 epidemic.
  • This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the project.

  • Further details on the project may be requested.
  • You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Consulting service as validated with the Expert.
Formulaire

Get started with your COVID-19 drug development consulting request

Please answer the fields below to be contacted by our team of scientists

favicon large un peu plus-1